1. Home
  2. ATOS vs STKE Comparison

ATOS vs STKE Comparison

Compare ATOS & STKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

HOLD

Current Price

$5.43

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

STKE

Sol Strategies Inc.

N/A

Current Price

$1.39

Market Cap

38.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ATOS
STKE
Founded
2009
2002
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.2M
38.3M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ATOS
STKE
Price
$5.43
$1.39
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$23.00
N/A
AVG Volume (30 Days)
53.0K
199.7K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,758.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$552.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.85
52 Week High
$7.56
$7.75

Technical Indicators

Market Signals
Indicator
ATOS
STKE
Relative Strength Index (RSI) 53.31 63.04
Support Level $0.66 $1.18
Resistance Level $5.56 $1.65
Average True Range (ATR) 0.34 0.11
MACD -0.02 0.06
Stochastic Oscillator 50.32 93.46

Price Performance

Historical Comparison
ATOS
STKE

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About STKE Sol Strategies Inc.

Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.

Share on Social Networks: